trastuzumab,neratinib
roche,puma
['neratinib', 'summit', 'puma']
#company_news_ puma biotechnology presents updated findings from the phase ii summit basket trial of neratinib for her2-mutant, recurrent/metastatic cervical cancer at the esmo congress 2022 
With over a thousand ETFs to choose from picking the right one can be complicated - Trading Strategies https://t.co/eUyJZgygom